I did listen to this webinar. There were three presenters,
Endpoints has just put up the questions asked, and answers, this was not on the webinar, and is interesting reading.
I will put a link here. The last point , i.e. , the relative ease , for running trials in OV therapy, with an IV dose needing .
minutes, compared to IV infusion in a clinic for four hours, is worth noting.
A brief summary:
Paul Peter Tak, Candel therapeutics, works with HSV virus, trial in Prostate cancer, IT , no IV. Study started 2011, completing Dec 2024 . ( talk about needing patience) also study into glioblastoma.
Howard Kaufman , CEO Ankara, also intratumoral only. Only “ clinical” work has been in dogs! Humans” coming soon”
Adina Pelusio . With KaliVir.. also using vaccinia, working on IV use. Again only clinical work in dogs. An unlisted company. She was impressive.
issuses discussed were , needing good study design, targeting the right tumour, RECIST esp tumour size, with regard to tumour pseudo progression.
All this prompted me to have a good look at T-VEC. AMGEN is a huge company, T-VEC is a good earner, but by no means their most important. Notably, they have no ongoing research into OV’s. I guess they just buy out what they want.
All up, I think if there is another update webinar in this field, I believe that YF will be invited . OV’s are a tough field, these speakers have been in it for decades. I’m feeling very good about CF 33 , etc
https://endpts.com/oncolytic-virus-experts-discuss-biggest-lessons-from-past-failures/
- Forums
- ASX - By Stock
- Ann: Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study
I did listen to this webinar. There were three presenters,...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
0.003(3.66%) |
Mkt cap ! $618.5M |
Open | High | Low | Value | Volume |
8.2¢ | 8.7¢ | 8.1¢ | $1.144M | 13.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 80226 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 1062609 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 518515 | 0.085 |
10 | 972049 | 0.084 |
11 | 10659658 | 0.083 |
7 | 252151 | 0.082 |
5 | 874405 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 923764 | 10 |
0.087 | 1384380 | 12 |
0.088 | 1225500 | 7 |
0.089 | 1621000 | 6 |
0.090 | 1056319 | 12 |
Last trade - 11.54am 30/04/2024 (20 minute delay) ? |
|
|||||
Last
8.7¢ |
  |
Change
0.003 ( 5.23 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.7¢ | 8.2¢ | 4358401 | ||
Last updated 12.11pm 30/04/2024 ? |
Featured News
IMU (ASX) Chart |